This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rose, D. P. Articles by Liu, X.-H. Search for Related Content PubMed PubMed Citation Articles by Rose, D. P. Articles by Liu, X.-H.

Effects of Linoleic Acid on the Growth and Metastasis of Two Human Breast Cancer Cell Lines in Nude Mice and the Invasive Capacity of These Cell Lines in Vitro¹

Division of Nutrition and Endocrinology, American Health Foundation, Valhalla, New York 10595

The purpose of the study was to compare the effects of dietary linoleic acid (LA) intake on the growth and metastasis of MDA-MB-435 and MDA-MB-231 human breast cancer cells in nude mice, together with their invasive capacity and secretion of type IV collagenase (gelatinase) in vitro. Each tumor cell line (10⁶ cells) was injected into a right-sided mammary fat pad in 60 mice with equal numbers (30 mice/group) assigned to isocaloric diets containing 23% (w/w) total fat and 2% or 12% (w/w) LA. The MDA-MB-435-cell mammary fat pad tumors became palpable earlier and initially they grew more rapidly, but by 6 weeks the MDA-MB-231-cell tumors exhibited an acceleration of growth which was enhanced by the high-LA diet. At necropsy, 12 weeks after the tumor cell injections, the mean weight [10.2 ± 1.4 g(SEM)] of mammary fat pad MDA-MB-231 cell tumors in 12% LA-fed mice was significantly higher (6.7 ± 1.4 g) than that of the mice fed 2% LA; also, it was higher than that of MDA-MB-435 cell tumors in the 12% LA-fed mice (3.6 ± 0.1 g) or the 2% LA-fed mice (3.3 ± 0.1 g) (each P < 0.001). Mice fed the 12% LA diet had a higher incidence of grossly visible MDA-MB-435 cell pulmonary metastatic nodules than those fed the 2% LA diet (67% versus 33%; P < 0.02), more metastatic lesions (5.7 ± 1.6 versus 2.3 ± 0.8; P < 0.05), and greater total volumes (62.0 ± 25.9 versus 24.8 ± 9.0 mm³; P < 0.02) per mouse. Of the MDA-MB-231 cell tumor-bearing mice, only 1 in the 12% LA dietary group and 2 in the 2% LA dietary group had macroscopic nodules but the incidence of microscopic metastases was 68 and 42%, respectively. The MDA-MB-231 cell line exhibited a relatively high capacity for invasion in vitro and constitutively high levels of both total type IV collagenolytic activity and M_r 92,000 gelatinase production which were unaffected by LA. In contrast, MDA-MB-435 cells had approximately only one-sixth the invasive capacity and secreted a relatively low level of type IV collagenase and little of the M_r 92,000 gelatinase; both invasion and enzyme production were stimulated by LA.

¹ This work was supported by American Cancer Society Grant CN-100.

² To whom requests for reprints should be addressed, at Division of Nutrition and Endocrinology, American Health Foundation, 1 Dana Road, Valhalla, NY 10595.

Received 7/ 6/94. Accepted 10/12/94.

This article has been cited by other articles:

				V. G. Kaklamani, M. Sadim, A. Hsi, K. Offit, C. Oddoux, H. Ostrer, H. Ahsan, B. Pasche, and C. Mantzoros Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk Cancer Res., May 1, 2008; 68(9): 3178 - 3184. [Abstract] [Full Text] [PDF]

				L. Vona-Davis and D. P Rose Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression Endocr. Relat. Cancer, June 1, 2007; 14(2): 189 - 206. [Abstract] [Full Text] [PDF]

				S. B. Kennett, J. D. Roberts, and K. Olden Requirement of Protein Kinase C{micro} Activation and Calpain-mediated Proteolysis for Arachidonic Acid-stimulated Adhesion of MDA-MB-435 Human Mammary Carcinoma Cells to Collagen Type IV J. Biol. Chem., January 30, 2004; 279(5): 3300 - 3307. [Abstract] [Full Text] [PDF]

				W. C. Wolf, D. M. Evans, L. Chao, and J. Chao A Synthetic Tissue Kallikrein Inhibitor Suppresses Cancer Cell Invasiveness Am. J. Pathol., November 1, 2001; 159(5): 1797 - 1805. [Abstract] [Full Text] [PDF]

				W. E. Hardman, C. P. R. Avula, G. Fernandes, and I. L. Cameron Three Percent Dietary Fish Oil Concentrate Increased Efficacy of Doxorubicin Against MDA-MB 231 Breast Cancer Xenografts Clin. Cancer Res., July 1, 2001; 7(7): 2041 - 2049. [Abstract] [Full Text] [PDF]

				L. A. Sauer, R. T. Dauchy, and D. E. Blask Mechanism for the Antitumor and Anticachectic Effects of n-3 Fatty Acids Cancer Res., September 1, 2000; 60(18): 5289 - 5295. [Abstract] [Full Text]

				D. J. Ruthig and K. A. Meckling-Gill Both (n-3) and (n-6) Fatty Acids Stimulate Wound Healing in the Rat Intestinal Epithelial Cell Line, IEC-6 J. Nutr., October 1, 1999; 129(10): 1791 - 1798. [Abstract] [Full Text]

				L. A. Sauer, R. T. Dauchy, D. E. Blask, B. J. Armstrong, and S. Scalici 13-Hydroxyoctadecadienoic Acid Is the Mitogenic Signal for Linoleic Acid-dependent Growth in Rat Hepatoma 7288CTC in Vivo Cancer Res., September 1, 1999; 59(18): 4688 - 4692. [Abstract] [Full Text] [PDF]

				V. E. Steele, C. A. Holmes, E. T. Hawk, L. Kopelovich, R. A. Lubet, J. A. Crowell, C. C. Sigman, and G. J. Kelloff Lipoxygenase Inhibitors as Potential Cancer Chemopreventives Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 467 - 483. [Abstract] [Full Text]